Commodore Capital »

Helix Acquisition Corp Iii shares owned by Commodore Capital

Quarter-by-quarter ownership of Helix Acquisition Corp Iii shares owned by Commodore Capital from 13F filings

Historical chart of Commodore Capital investment in Helix Acquisition Corp Iii

Tip: Access up to 7 years of quarterly data

All positions including Helix Acquisition Corp Iii held by Commodore Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Helix Acquisition Corp Iii by Commodore Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $5.1M 500k 10.16

More positions owned by Commodore Capital

Relay Therapeutics (RLAY)
Alkermes SHS (ALKS)
Enliven Therapeutics (ELVN)
Cogent Biosciences (COGT)
Spyre Therapeutics Com New (SYRE)
Tyra Biosciences (TYRA)
Celldex Therapeutics Com New (CLDX)
Nuvalent Inc-a (NUVL)
Amylyx Pharmaceuticals (AMLX)
Kymera Therapeutics (KYMR)
Alto Neuroscience Com Shs (ANRO)
Pharvaris N V (PHVS)
Erasca (ERAS)
Damora Therapeutics Com New (DMRA)
Xenon Pharmaceuticals (XENE)

View all positions for Commodore Capital

Top funds holding Helix Acquisition Corp Iii

Cormorant Asset Management
RA Capital Management
Nantahala Capital Management
ADAR1 Capital Management
Balyasny Asset Management
Braidwell
Toronto-Dominion Bank
Millennium Management
OZ Management
Commodore Capital
Sona Asset Management
Stempoint Capital
Two Sigma Investments
Longaeva Partners
Berkley W R

View all funds holding Helix Acquisition Corp Iii